4 hours NVS vs. LLY: Which Stock Is the Better Value Option?Zacks NVS vs. LLY: Which Stock Is the Better Value Option? Eli Lilly (LLY) · Pharmaceuticals X
6 hours Warther Private Wealth LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)MarketBeat X
22 hours Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to KnowZacks X
1 day Viking Therapeutics Skyrockets After Dealing A Blow To Eli Lilly’s Obesity TripletInvestor's Business Daily X
1 day Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market AwaitsThe Motley Fool X
2 days Goldman Sachs: Eli Lilly and Company (NYSE:LLY) Has Got Mutual & Hedge Fund Managers DividedInsider Monkey X
2 days Regeneron Pharmaceuticals (NASDAQ:REGN) Receives “Neutral” Rating from Cantor FitzgeraldMarketBeat X
2 days Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Lowered to $1,080.00 at BarclaysMarketBeat X
2 days The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and BiogenZacks X
2 days Sequoia Financial Advisors LLC Raises Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)MarketBeat X
2 days Sequoia Financial Advisors LLC Increases Stake in Eli Lilly and Company (NYSE:LLY)MarketBeat X
2 days This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly’s StockThe Motley Fool X
3 days Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Cut to $1,050.00 by Analysts at Wells Fargo & CompanyMarketBeat X
3 days Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High – Here’s What HappenedMarketBeat X
3 days Regeneron Pharmaceuticals (NASDAQ:REGN) Earns “Outperform” Rating from Royal Bank of CanadaMarketBeat X
3 days Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of “Moderate Buy” from AnalystsMarketBeat X
3 days Plimoth Trust Co. LLC Has $4.63 Million Stock Position in Eli Lilly and Company (NYSE:LLY)MarketBeat X
3 days Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Given Average Rating of “Moderate Buy” by BrokeragesMarketBeat X
3 days Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What HappenedMarketBeat X
3 days Creative Planning Purchases 2,178 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)MarketBeat X
4 days Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives Consensus Rating of “Moderate Buy” from AnalystsMarketBeat X
4 days Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading Volume – Should You Buy?MarketBeat X
4 days 50,500 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Purchased by Toth Financial Advisory CorpMarketBeat X
4 days 2,265 Shares in Eli Lilly and Company (NYSE:LLY) Bought by Penn Davis Mcfarland Inc.MarketBeat X
4 days Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Boosted by Raymond James & AssociatesMarketBeat X
5 days Chicago Capital LLC Has $54.63 Million Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)MarketBeat X
5 days Eli Lilly and Company (NYSE:LLY) Shares Purchased by First Citizens Bank & Trust Co.MarketBeat X
5 days 1,479 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by Net Worth Advisory GroupMarketBeat X
5 days Claro Advisors LLC Has $644,000 Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL)MarketBeat X
6 days SG Americas Securities LLC Sells 18,463 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)MarketBeat X
6 days Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Consensus Rating of “Moderate Buy” by BrokeragesMarketBeat X
6 days Friedenthal Financial Takes Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)MarketBeat X
1 week Eli Lilly (LLY): Revenue Boost from Zepbound and Mounjaro Amid Strong Market ProjectionsInsider Monkey X